Effect of body mass index on quality of life in allergic/asthmatic patients

dc.contributor.authorKalpaklıoğlu, A. Füsun
dc.contributor.authorKara, Türkan
dc.contributor.authorKurtipek, Ercan
dc.contributor.authorSaygun, Meral
dc.date.accessioned2020-06-25T17:41:22Z
dc.date.available2020-06-25T17:41:22Z
dc.date.issued2006
dc.description24th Congress of the European-Academy-of-Allergology-and-Clinical-Immunology -- JUN 26-JUL 01, 2005 -- Munich, GERMANY
dc.description.abstractEvaluation of quality of life (QoL) is of particular interest in patients suffering from chronic diseases. Although studies have shown an association between QoL and obesity and allergy/asthma, the effect of obesity on QoL is not well known. The aim of this study was to assess the impact of body mass index (BMI) as a contributory factor on QoL in patients with a diagnostic label of allergy/asthma. We surveyed 100 patients (69 F/31 M) (age 34.15 +/- 13.32 years), and 65 healthy controls (42 F/23 M) (age 35.45 +/- 8.96 years). QoL was determined by SF-36. BMI >= 25 kg/m(2) was accepted as overweight/obesity. Forty-five percent of the patients had BMI >= 25 kg/m(2) with no difference between the genders. They were significantly older and more likely to have less education level than those with BMI < 25 kg/m(2). Quality-of-life scores among patients with allergy/asthma were lower than those in the control group, irrespective of BMI. However, increased BMI was found to be related with improved quality of life among controls. Pearson's analysis showed that BMI was inversely correlated with physical functioning among patients (r = -0.229, p = 0.034), but in the control group it was positively correlated with QoL. All the domains of SF-36, except role-physical ones, among female subjects were significantly impaired more than those of male patients. It has been shown that the major determinants of impaired QoL are female sex, older age, and less educational status in patients with allergic/asthmatic symptoms. The impact of BMI on QoL could be undermined, because it seems to play a minor role.en_US
dc.description.sponsorshipEuropean Acad Allergol Clin Immunolen_US
dc.identifier.citationclosedAccessen_US
dc.identifier.doi10.2500/aap.2006.27.2909
dc.identifier.endpage503en_US
dc.identifier.issn1088-5412
dc.identifier.issn1539-6304
dc.identifier.issue6en_US
dc.identifier.pmid17176785
dc.identifier.scopus2-s2.0-33845477692
dc.identifier.scopusqualityQ2
dc.identifier.startpage499en_US
dc.identifier.urihttps://doi.org10.2500/aap.2006.27.2909
dc.identifier.urihttps://hdl.handle.net/20.500.12587/3694
dc.identifier.volume27en_US
dc.identifier.wosWOS:000242195700012
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherOcean Side Publications Incen_US
dc.relation.ispartofAllergy And Asthma Proceedings
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleEffect of body mass index on quality of life in allergic/asthmatic patientsen_US
dc.typeConference Object

Dosyalar